NO321237B1 - Vaksiner, samt anvendelse av svekkede T-celler til fremstilling av et medikament for formidling av immunrespons i en pasient. - Google Patents

Vaksiner, samt anvendelse av svekkede T-celler til fremstilling av et medikament for formidling av immunrespons i en pasient. Download PDF

Info

Publication number
NO321237B1
NO321237B1 NO20001421A NO20001421A NO321237B1 NO 321237 B1 NO321237 B1 NO 321237B1 NO 20001421 A NO20001421 A NO 20001421A NO 20001421 A NO20001421 A NO 20001421A NO 321237 B1 NO321237 B1 NO 321237B1
Authority
NO
Norway
Prior art keywords
cells
myelin
vaccine
use according
administered
Prior art date
Application number
NO20001421A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001421D0 (no
NO20001421L (no
Inventor
Leslie P Weiner
Jorge D Correale
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26738869&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO321237(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of NO20001421D0 publication Critical patent/NO20001421D0/no
Publication of NO20001421L publication Critical patent/NO20001421L/no
Publication of NO321237B1 publication Critical patent/NO321237B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20001421A 1997-09-19 2000-03-17 Vaksiner, samt anvendelse av svekkede T-celler til fremstilling av et medikament for formidling av immunrespons i en pasient. NO321237B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5953497P 1997-09-19 1997-09-19
US09/156,509 US20020009448A1 (en) 1997-09-19 1998-09-17 T-cell vaccination for the treatment of multiple sclerosis
PCT/US1998/019572 WO1999013904A1 (en) 1997-09-19 1998-09-18 T-cell vaccination for the treatment of multiple sclerosis

Publications (3)

Publication Number Publication Date
NO20001421D0 NO20001421D0 (no) 2000-03-17
NO20001421L NO20001421L (no) 2000-05-19
NO321237B1 true NO321237B1 (no) 2006-04-10

Family

ID=26738869

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001421A NO321237B1 (no) 1997-09-19 2000-03-17 Vaksiner, samt anvendelse av svekkede T-celler til fremstilling av et medikament for formidling av immunrespons i en pasient.

Country Status (8)

Country Link
US (2) US20020009448A1 (de)
EP (1) EP1015025B1 (de)
AT (1) ATE284708T1 (de)
AU (1) AU755884B2 (de)
CA (1) CA2304373A1 (de)
DE (1) DE69828179D1 (de)
NO (1) NO321237B1 (de)
WO (1) WO1999013904A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050220908A1 (en) * 2004-03-30 2005-10-06 Theoharides Theoharis C Anti-inflammatory compositions for multiple sclerosis
US7906153B2 (en) * 1998-04-08 2011-03-15 Theta Biomedical Consulting & Development Co., Inc. Anti-inflammatory compositions for treating multiple sclerosis
US6541608B1 (en) * 1999-02-23 2003-04-01 Baylor College Of Medicine T cell receptor Vβ-Dβ-Jβ sequence and methods for its detection
US7541184B2 (en) * 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
CN1541105A (zh) 2001-06-11 2004-10-27 转新疗法公司 用维生素b12和干扰素联合治疗病毒性、增殖性和炎性疾病的方法
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
US20050084967A1 (en) * 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20040175373A1 (en) * 2002-06-28 2004-09-09 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
CN100567987C (zh) * 2002-08-08 2009-12-09 贝勒医学院 T细胞疫苗及其制备方法
AU2003299914A1 (en) 2002-12-31 2004-07-29 Baylor College Of Medicine Isolation and identification of cross-reactive t cells
AU2007247869B2 (en) * 2006-05-05 2013-11-21 Opexa Therapeutics T-cell vaccine
PL2318020T3 (pl) * 2008-06-30 2016-02-29 Univ Heidelberg Immunosupresyjne komórki krwi i sposób ich wytwarzania
AU2017271122B2 (en) 2016-05-25 2023-10-26 The Council Of The Queensland Institute Of Medical Research Methods of immunotherapy
KR20190124214A (ko) * 2017-01-20 2019-11-04 아타라 바이오테라퓨틱스 인크. 자가 t 세포를 사용하여 다발성 경화증을 치료하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
IL165071A (en) * 1990-03-30 2008-06-05 Autoimmune Inc A peptide with the ability to stimulate a subset of T cells from multiple sclerosis patients
US5849886A (en) * 1996-07-10 1998-12-15 Oy Aboatech Ab Extraction of myelin basic protein
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods

Also Published As

Publication number Publication date
AU9571398A (en) 1999-04-05
AU755884B2 (en) 2003-01-02
EP1015025A1 (de) 2000-07-05
WO1999013904A1 (en) 1999-03-25
US20040156860A1 (en) 2004-08-12
DE69828179D1 (de) 2005-01-20
EP1015025B1 (de) 2004-12-15
ATE284708T1 (de) 2005-01-15
NO20001421D0 (no) 2000-03-17
CA2304373A1 (en) 1999-03-25
US20020009448A1 (en) 2002-01-24
NO20001421L (no) 2000-05-19

Similar Documents

Publication Publication Date Title
NO321237B1 (no) Vaksiner, samt anvendelse av svekkede T-celler til fremstilling av et medikament for formidling av immunrespons i en pasient.
Peng et al. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis
Correale et al. T cell vaccination in secondary progressive multiple sclerosis
Anderson et al. Distinct roles for donor-and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ
van Noort et al. Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis
Openshaw et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring
Kipnis et al. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity
US20070286849A1 (en) Treatment of autoimmune disorders
DE69837324T2 (de) Behandlung der multiplen sklerose durch einnahme von copolymer-1
WO2009056332A1 (en) Use of modified cells for the treatment of multiple sclerosis
AU2002345323B2 (en) Use of poly-Glu, Tyr for neuroprotective therapy
EP3320914B1 (de) Th1-typ adjuvans zur behandlung von amyotropher lateralsklerose
WO2009050283A1 (en) Compositions for treating multiple sclerosis
AU2002345323A1 (en) Use of poly-Glu, Tyr for neuroprotective therapy
Paterka et al. Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis
Kline et al. Optic neuritis and myelitis following rubella vaccination
Nieto-Aristizábal et al. From ocular immune privilege to primary autoimmune diseases of the eye
WO2008002996A2 (en) Rheumatoid arthritis t cell vaccine
CN101229370B (zh) 自体t-细胞疫苗材料和方法
Brocke et al. Experimental autoimmune encephalomyelitis in the mouse
Hermans et al. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination
Marini et al. A CD4-CDR3 peptide analog inhibits both primary and secondary autoreactive CD4+ T cell responses in experimental allergic encephalomyelitis
RU2209633C2 (ru) Т-клеточная вакцина для лечения рассеянного склероза
Jung et al. T cell vaccination does not induce resistance to experimental autoimmune neuritis
Besnier et al. Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees